228 related articles for article (PubMed ID: 25612993)
1. [Ipilimumab treatment of metastatic melanoma].
Ghasemi H; Schmidt H; Stolle LB
Ugeskr Laeger; 2015 Jan; 177(2A):108-9. PubMed ID: 25612993
[TBL] [Abstract][Full Text] [Related]
2. Ipilimumab: a novel immunostimulatory monoclonal antibody for the treatment of cancer.
Graziani G; Tentori L; Navarra P
Pharmacol Res; 2012 Jan; 65(1):9-22. PubMed ID: 21930211
[TBL] [Abstract][Full Text] [Related]
3. [Immune checkpoint antibodies increase survival in patients with metastatic melanoma].
Fløe LE; Svane IM; Bastholt L; Schmidt H
Ugeskr Laeger; 2016 Aug; 178(33):. PubMed ID: 27550784
[TBL] [Abstract][Full Text] [Related]
4. Ipilimumab in the treatment of metastatic melanoma: a summary of recent studies.
Ascierto PA
Tumori; 2013; 99(6):302e-5e. PubMed ID: 24503809
[TBL] [Abstract][Full Text] [Related]
5. Ipilimumab induces simultaneous regression of melanocytic naevi and melanoma metastases.
Libon F; Arrese JE; Rorive A; Nikkels AF
Clin Exp Dermatol; 2013 Apr; 38(3):276-9. PubMed ID: 23020081
[TBL] [Abstract][Full Text] [Related]
6. Ipilimumab approved for metastatic melanoma.
Traynor K
Am J Health Syst Pharm; 2011 May; 68(9):768. PubMed ID: 21515855
[No Abstract] [Full Text] [Related]
7. Ipilimumab in the treatment of melanoma.
Trinh VA; Hwu WJ
Expert Opin Biol Ther; 2012 Jun; 12(6):773-82. PubMed ID: 22500861
[TBL] [Abstract][Full Text] [Related]
8. The ipilimumab lesson in melanoma: achieving long-term survival.
Delyon J; Maio M; Lebbé C
Semin Oncol; 2015 Jun; 42(3):387-401. PubMed ID: 25965357
[TBL] [Abstract][Full Text] [Related]
9. Complete regression of a previously untreated melanoma brain metastasis with ipilimumab.
Schartz NE; Farges C; Madelaine I; Bruzzoni H; Calvo F; Hoos A; Lebbé C
Melanoma Res; 2010 Jun; 20(3):247-50. PubMed ID: 20216240
[TBL] [Abstract][Full Text] [Related]
10. [Metastatic melanoma: some hope from ipilimumab and vemurafenib].
Piérard-Franchimont C; Piérard GE
Rev Med Liege; 2012 Feb; 67(2):64-8. PubMed ID: 22482234
[TBL] [Abstract][Full Text] [Related]
11. Ipilimumab: attenuation of an inhibitory immune checkpoint improves survival in metastatic melanoma.
Peggs KS; Quezada SA
Expert Rev Anticancer Ther; 2010 Nov; 10(11):1697-701. PubMed ID: 21080797
[TBL] [Abstract][Full Text] [Related]
12. Profile of ipilimumab and its role in the treatment of metastatic melanoma.
Patel SP; Woodman SE
Drug Des Devel Ther; 2011; 5():489-95. PubMed ID: 22267918
[TBL] [Abstract][Full Text] [Related]
13. Ipilimumab in melanoma patients with brain metastasis: a retro-spective multicentre evaluation of thirty-eight patients.
Konstantinou MP; Dutriaux C; Gaudy-Marqueste C; Mortier L; Bedane C; Girard C; Thellier S; Jouary T; Grob JJ; Richard MA; Templier C; Sakji L; Guillot B; Paul C; Meyer N
Acta Derm Venereol; 2014 Jan; 94(1):45-9. PubMed ID: 23824275
[TBL] [Abstract][Full Text] [Related]
14. Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trial.
Weber JS; Amin A; Minor D; Siegel J; Berman D; O'Day SJ
Melanoma Res; 2011 Dec; 21(6):530-4. PubMed ID: 22051508
[TBL] [Abstract][Full Text] [Related]
15. Treatment possibilities of ipilimumab-induced thrombocytopenia--case study and literature review.
Kopecký J; Trojanová P; Kubeček O; Kopecký O
Jpn J Clin Oncol; 2015 Apr; 45(4):381-4. PubMed ID: 25583422
[TBL] [Abstract][Full Text] [Related]
16. Sweet's syndrome in a patient with metastatic melanoma after ipilimumab therapy.
Pintova S; Sidhu H; Friedlander PA; Holcombe RF
Melanoma Res; 2013 Dec; 23(6):498-501. PubMed ID: 24113862
[TBL] [Abstract][Full Text] [Related]
17. [Metastatic malignant melanoma. Successfull treatment with ipilimumab].
Jansen T; Bruch-Gerharz D; Reifenberger J; Schulte KW
Hautarzt; 2013 Apr; 64(4):228, 230-1. PubMed ID: 23576166
[TBL] [Abstract][Full Text] [Related]
18. Successful Anti-PD-1 Antibody Treatment in a Metastatic Melanoma Patient With Known Severe Autoimmune Disease.
Maul LV; Weichenthal M; Kähler KC; Hauschild A
J Immunother; 2016 May; 39(4):188-90. PubMed ID: 27023060
[TBL] [Abstract][Full Text] [Related]
19. Ipilimumab in treatment-naive and previously treated patients with metastatic melanoma: retrospective analysis of efficacy and safety data from a phase II trial.
Thompson JA; Hamid O; Minor D; Amin A; Ron IG; Ridolfi R; Assi H; Berman D; Siegel J; Weber JS
J Immunother; 2012 Jan; 35(1):73-7. PubMed ID: 22130164
[TBL] [Abstract][Full Text] [Related]
20. Ipilimumab in advanced melanoma: reports of long-lasting responses.
Farolfi A; Ridolfi L; Guidoboni M; Nicoletti SV; Piciucchi S; Valmorri L; Costantini M; Scarpi E; Amadori D; Ridolfi R
Melanoma Res; 2012 Jun; 22(3):263-70. PubMed ID: 22516968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]